OCCIDENT

OCCIDENT

OCCIDENT is a venture capital investor that operates internationally

OCCIDENT is a venture capital investor that operates internationally. The firm is interested in early-stage venture as well as seed opportunities. The firm was founded in 1993 in Zug, Zug, Switzerland.

The firm is interested in managing wealth in sustainable companies that contribute positively towards society. OCCIDENT is interested in long-term oriented, innovative start-ups and visionary founders. The firm is fascinated by technology sound topics such as deep tech, life sciences, digital and high tech sectors.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
Tubulis Therapeutics

Tubulis Therapeutics is a Munich-based therapeutics company developing matched protein-drug conjugates.

GNA Biosolutions is a Martinsried-based molecular diagnostics company.

AdvanceCOR is a Planegg-based company developing drugs and diagnostics for the treatment of cardiovascular diseases founded in 2012 by Martin Lohse.

4 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.